Multiple Sclerosis Clinical Trial

Genes and Environment in Multiple Sclerosis

Summary

The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.

View Full Description

Full Description

MS is an autoimmune disease in which the immune system (white bloods cells that normally fight infection) becomes misdirected and attacks healthy tissue. In patients with MS, the misdirected white blood cells attack myelin, a lining that insulates the nerves found in the brain and spinal cord. This results in inflammation and damage in the myelin. Loss of this protective lining disrupts nerve impulses and causes abnormal function in the nervous system.

This large research study will ultimately enroll 5000 subjects who are at risk of developing MS.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

First Degree Relatives of Patients with MS, or
Patients who have received anti-TNFa therapy as treatment for inflammatory diseases other than MS such as Crohn's disease, psoriasis and rheumatoid arthritis, or
Patients that have been referred for an evaluation of first presentation of neurologic symptoms but do not have a diagnosis of MS
Live in the United States

Exclusion Criteria:

Does not match any of the inclusion criteria

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

5000

Study ID:

NCT01353547

Recruitment Status:

Recruiting

Sponsor:

Columbia University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

National Institute of Neurological Disorders and Stroke
Bethesda Maryland, 15213, United States More Info
Daniel S Reich, MD, PhD
Principal Investigator
Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Brigham and Women's Hospital
Boston Massachusetts, 02115, United States
Columbia University Irving Center
New York New York, 10032, United States More Info
Fatoumata Diallo, BS
Contact
212-305-1485
[email protected]
Kaho Onomichi, MS
Contact
212-305-9155
Philip L De Jager, MD, PhD
Principal Investigator
University of Pittsburgh
Pittsburgh Pennsylvania, 15213, United States More Info
Zongqi Xia, MD, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

5000

Study ID:

NCT01353547

Recruitment Status:

Recruiting

Sponsor:


Columbia University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider